Hepatitis C: all 2,356 studies
Page 11 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Observational Cohort Study of Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04071353
- SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis CStatus unknownNCT04070235Phase 2/3
- HCV Treatment in a Low-threshold ClinicStatus unknownNCT04063839
- Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in MadridCompletedNCT04062253
- Eliminate Hepatitis C/EC Partnership Evaluation ProtocolStatus unknownNCT04061551Not applicable
- Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant StudyTerminatedNCT04057001
- Zepatier in Patients with Substance UseCompletedNCT04048850
- eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAsCompletedNCT04047680
- HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)Status unknownNCT04044586
- Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in BrazilStatus unknownNCT04039698Not applicable
- Simplified Antiviral Treatment Strategy for Hepatitis C in UkraineCompletedNCT04038320
- Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer ScreeningCompletedNCT04037046Not applicable
- Implementation and Evaluation of Care Coordination in Linkage to Care for Hepatitis C Following Release From New York City JailsCompletedNCT04036760
- Evaluation Study of RDTs Detecting Antibodies Against HCVCompletedNCT04033887
- Re-engaging Patients With Hepatitis C Into CareStatus unknownNCT04029246Not applicable
- The DETECT HCV Linkage to Care TrialCompletedNCT04026867Not applicable
- Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) InfectionCompletedNCT04019717Phase 2
- Transplantation Using Hepatitis C Positive Donors, A Safety TrialStatus unknownNCT04017338Phase 3
- Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe ProgramsCompletedNCT04014179Not applicable
- A Community-based Intervention Among Active Drug Users in MontpellierCompletedNCT04008927Not applicable
- Prevalence of HCV in HIV-negative MSMStatus unknownNCT04005248Not applicable
- Self-testing for HCV Re-infection in MSMStatus unknownNCT04004299Not applicable
- The DETECT HCV Screening TrialCompletedNCT04003454Not applicable
- Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection PatientsStatus unknownNCT04001608Phase 3
- KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis CCompletedNCT03995485Phase 3
- Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong KongActive, not recruitingNCT03993925
- Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in CambodiaCompletedNCT03992313Not applicable
- Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject DrugsTerminatedNCT03981211Not applicable
- Screening Hepatitis Positive Women for Congenital AnomaliesCompletedNCT03980301
- Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PDStatus unknownNCT03973502Not applicable
- Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C VirusCompletedNCT03961828Phase 4
- Glecaprevir/Pibrentasvir Real-world Study in ChinaStatus unknownNCT03941821
- Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)CompletedNCT03939013Not applicable
- A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative MeasuresStatus unknownNCT03932396
- Puglia HCV Micro-elimination ProgramCompletedNCT03923595
- Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral AgentsCompletedNCT03908294
- Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological MalignancyCompletedNCT03903185Phase 1/2
- The Tolerability and Pharmacokinetics Study of HEC110114 Tablets in Healthy Adult SubjectsCompletedNCT03903081Phase 1
- Evaluation of Dried Blood Spot for HCV RNA TestingCompletedNCT03896087Not applicable
- Effect of Strategies for the Treatment of Chronic Hepatitis C in ColombiaStatus unknownNCT03895294Not applicable
- Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral AgentsStatus unknownNCT03894696
- Micro-elimination of Hepatitis C Virus Infection in UremicsStatus unknownNCT03891550Phase 3
- Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)Status unknownNCT03888729Phase 4
- Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)Status unknownNCT03887637
- Safety of Sofosbuvir in People With Advanced Kidney FailureCompletedNCT03883698Phase 3
- Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients SeraStatus unknownNCT03882307Early Phase 1
- Direct Acting Antivirals for HCV Infection in Kidney Transplant RecipientsCompletedNCT03880682
- Conquering Hepatitis C Via Micro-Elimination in Southwest VirginiaStatus unknownNCT03876470
- Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian FederationCompletedNCT03868163
- HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in EgyptCompletedNCT03839979
- Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)CompletedNCT03833362Phase 3
- Tool to Improve Treatment Adherence and Outcomes at Grady Liver ClinicCompletedNCT03831555Not applicable
- Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/VelpatasvirCompletedNCT03818308Phase 2
- Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole TabletCompletedNCT03817619Phase 1
- Hepatitis C Patient Management and Family Health EducationStatus unknownNCT03813498Not applicable
- The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult SubjectsCompletedNCT03811678Phase 1
- The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant RecipientsActive, not recruitingNCT03809533Phase 2
- Motivational Interviewing for HCV EliminationTerminatedNCT03804814Not applicable
- Surveillance of HCV in Uremics and Linking to Medical CareCompletedNCT03803410
- ATTIC - Access To Treat in the CommunityTerminatedNCT03797066Phase 4
- A Comprehensive HBsAg-positive Patients Centered Screening StrategyCompletedNCT03794791
- Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b InfectionWithdrawnNCT03794258Phase 2
- A Prospective Cohort Study to Improve HCV Care in Dialysis PatientsWithdrawnNCT03791814Phase 4
- Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to EliminationStatus unknownNCT03776760
- Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.Status unknownNCT03775798
- Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in JiangsuStatus unknownNCT03772002Not applicable
- Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 YearsCompletedNCT03764345Not applicable
- Treatment of Egyptian Hepatitis C Genotype 4 Infected Children and Adolescents With Combined Ledipasvir/SofosbuvirStatus unknownNCT03743727Phase 4
- Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison SettingCompletedNCT03740906
- An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New DrugsCompletedNCT03740230
- Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney TransplantationTerminatedNCT03723824Phase 4
- Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.Status unknownNCT03721627Phase 4
- Behavioral Science and Hepatitis C Screening OutreachCompletedNCT03712553Not applicable
- A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND StudyCompletedNCT03710252Phase 4
- Direct Acting Antiviral-Post Authorization Safety StudyCompletedNCT03707080
- STOP HCC: Mailed HCV Treatment Outreach Program for HCC PreventionCompletedNCT03706742Not applicable
- Hepatocellular Carcinoma in HIV-infected Individuals in Asian PopulationCompletedNCT03702998
- Hepatitis C Positive Donor Into Hepatitis C Negative RecipientsWithdrawnNCT03702218Early Phase 1
- Ask a Friend to Take a Test for Hepatitis C InfectionCompletedNCT03697135
- Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for VasculitisCompletedNCT03693586
- Class II Invariant Chain HCV Vaccine StudyCompletedNCT03688061Phase 1
- The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV PatientsStatus unknownNCT03687229
- Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of MetforminCompletedNCT03686722Phase 1
- Oral Microbiome of Patients With Hepatitis C Virus InfectionCompletedNCT03682549
- Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus InfectionCompletedNCT03674125Phase 1
- The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult SubjectsCompletedNCT03673696Phase 1
- Evaluation of Hepatitis C Viral Load Quantification on DBS in VietnamCompletedNCT03670251Not applicable
- The Sublimated Mare Milk Supplement in Hepatitis CCompletedNCT03669835Not applicable
- Advanced Electronic Population Health and Personal Health Record Tools to Improve Once Lifetime Hepatitis C ScreeningCompletedNCT03654365Not applicable
- IFNL4 Genotype for Predicting Response to Ledipasvir/SofosbuvirWithdrawnNCT03639207
- Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney TransplantWithdrawnNCT03623568Phase 4
- Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver CirrhosisCompletedNCT03620474Phase 1/2
- Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral TherapyCompletedNCT03612973Not applicable
- Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV InfectionCompletedNCT03603327Not applicable
- Feasibility of Implementing a Cohort of People Living With Hepatitis C in VietnamCompletedNCT03601546
- Evaluation of HCV Viremia Testing Approaches Among PWID in GeorgiaCompletedNCT03594838Not applicable
- Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver DiseaseStatus unknownNCT03591783
- Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV InfectionCompletedNCT03588923Phase 1
- Prevalence of Hepatitis c Virus Infection Among Rheumatological PatientsCompletedNCT03587714
- A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease RiskWithdrawnNCT03585101Phase 4